Description: Critical illness insurance is a popular supplemental health insurance product in the U.S. market. This article discusses how carriers have recently sought to add value by expanded the benefits offered in their critical illness products. Specifically, the article discusses the consumer need and development considerations of adding benefits for autism Spectrum Disorder, Mental health disorders, Specified Disease Coverage, and enhance Cancer Coverage to a critical illness contract.

Description: Feature article with helpful hints on video conferencing and more!

Description: Discussion of recent developments in the taxation of noncoordinated benefits such as fixed indemnity, hospital indemnity, and specified disease insurance policies. Developments include a recent Chief Counsel Advice Memorandum and proposed triagency rulemaking that would impact non coordinated benefits.

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.

Description: This article provides an overview of critical illness insurance: history, product description, and the three primary ways to offer critical illness coverage in the United States. This article also contains an illustration of an issue age premium rate calculation, as well as product features and rating applications specific to the various types of critical illness coverage.

Description: This article announces the following reports on AIDS available from The Canadian Institute of Actuaries: 1. Memorandum covering AIDS from the Chairman of the Committee on Life Insurance Company Financial Reporting, 2. 1988 Guidance Notes for Valuation Actuaries, Report of the Subcommittee on Valuation, Task Force on AIDS, 3. First Report of the Subcommittee on Modeling, Task Force on AIDS, and 4. Second Report of the Subcommittee on Modeling, Task Force on AIDS, An Analysis of USA Data.

Description: Panelists examine various types of critical illness plans, its success in Canada and other markets, and the challenges and opportunities for the U.S. market.

Description: This session explores the aspects and the issues of offering a critical illness product in various markets, including individual, group, worksite and direct response. From the Record of the Society of Actuaries, Volume 28, No. 3, Session 7

Description: The panelists in this session discuss the current state of the CI market in the United States and Canada as well as an overview of seveal other countries. Specific topics to be addressed include product features, marketing and producer issues. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 24

Description: After witnessing strong sales of similar products in Japan and the United Kingdom, a number of U.S. insurers have recently jumped aboard the critical illness insurance express and are developing this product for sale in the United States.